Cantor Fitzgerald Forecasts Strong Price Appreciation for Acadia Healthcare (NASDAQ:ACHC) Stock

Acadia Healthcare (NASDAQ:ACHC) had its target price raised by equities research analysts at Cantor Fitzgerald from $30.00 to $39.00 in a research note issued on Friday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Cantor Fitzgerald‘s price objective suggests a potential upside of 12.10% from the company’s current price.

Other analysts have also issued research reports about the company. KeyCorp increased their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. Leerink Partners upped their target price on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research report on Wednesday, September 23rd. TD Cowen increased their price target on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Finally, UBS Group increased their price target on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $31.62.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $34.79 on Friday. The company’s 50-day moving average price is $29.27 and its 200-day moving average price is $26.03. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The company has a market cap of $3.24 billion, a PE ratio of -2.79, a price-to-earnings-growth ratio of 10.39 and a beta of 0.64. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $39.38.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.46 by $0.14. The company had revenue of $895.31 million during the quarter, compared to analyst estimates of $877.76 million. Acadia Healthcare had a negative net margin of 33.07% and a positive return on equity of 6.58%. Acadia Healthcare’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.72 earnings per share. On average, equities research analysts forecast that Acadia Healthcare will post 1.55 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Several large investors have recently made changes to their positions in the company. Fifth Third Bancorp boosted its holdings in Acadia Healthcare by 62.9% during the third quarter. Fifth Third Bancorp now owns 184,629 shares of the company’s stock worth $5,077,000 after buying an additional 71,304 shares in the last quarter. Maryland State Retirement & Pension System increased its holdings in Acadia Healthcare by 54.8% in the third quarter. Maryland State Retirement & Pension System now owns 20,674 shares of the company’s stock valued at $569,000 after buying an additional 7,316 shares in the last quarter. Jefferies Financial Group Inc. increased its holdings in Acadia Healthcare by 2.7% in the third quarter. Jefferies Financial Group Inc. now owns 3,703,240 shares of the company’s stock valued at $101,839,000 after buying an additional 98,173 shares in the last quarter. Penn Capital Management Company LLC acquired a new position in shares of Acadia Healthcare in the third quarter worth about $15,434,000. Finally, Prescott Group Capital Management L.L.C. raised its position in shares of Acadia Healthcare by 40.0% in the third quarter. Prescott Group Capital Management L.L.C. now owns 70,000 shares of the company’s stock worth $1,925,000 after acquiring an additional 20,000 shares during the period.

Acadia Healthcare News Roundup

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.60 per share, beating the $0.46 consensus estimate, while revenue of $895.3 million exceeded forecasts of $877.8 million and grew 5.1% year over year. Same-facility revenue rose 5.2%, supported by higher patient days and revenue per patient day. Acadia Healthcare Q3 results and guidance
• Positive Sentiment: Acadia raised its full-year 2026 financial guidance. The earnings-call coverage also pointed to stronger growth ahead, reinforcing the outlook beyond the quarterly beat. Earnings call growth outlook
• Neutral Sentiment: Barclays raised its price target from $32 to $35 but kept an “equal weight” rating, indicating a more measured view of further upside. Barclays price target
• Negative Sentiment: Despite beating estimates, quarterly EPS declined from $0.72 in the year-ago period to $0.60, a year-over-year earnings headwind.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.